Hinweis-Modus ist eingeschaltet Ausschalten

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FINDEN, SPEICHERN & VERFOLGEN SIE INVESTITIONEN MIT DER CBONDS WATCHLIST

Dank der Cbonds Watchlist bleiben Sie stets über Ihre Investitionen informiert und können fundierte Entscheidungen treffen!

Watchlist
Sie benötigen einen Zugang

Alle auswählen Alle zurücksetzen
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Fondstyp
SPDR State Street Global Advisors
Anbieter
157,39 USD
NAV pro Aktie | 14/08/2026
31/01/2006
Startdatum
4 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Gesamtkostenquote
10.602,03 Mio. USD
Gesamtes Fondsvermögen | 13/08/2026
Nein
UCITS
1 / 3 (11/09/2015)
Split

Rendite auf 14/08/2026, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1J
    62,15 %
  • 3J
    51,47 %
  • 5J
    0,91 %
  • 10J
    143,19 %
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen
von
zu
ADD-IN
Cbonds Add-In API
API Anleihen-Daten

Kurse (XBI)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In
Zugang erhalten

Kurs-Dynamik

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Struktur XBI auf 13/08/2026

Struktur in Excel herunterladen
Wertpapier Wertpapier
TWIST BIOSCIENCE CORP 1,76%
ORUKA THERAPEUTICS INC 1,61%
APOGEE THERAPEUTICS INC 1,55%
PRAXIS PRECISION MEDICINES I 1,46%
KYMERA THERAPEUTICS INC 1,39%
NATERA INC 1,37%
DIANTHUS THERAPEUTICS INC 1,37%
PROTAGONIST THERAPEUTICS INC 1,36%
HALOZYME THERAPEUTICS INC 1,36%
REVOLUTION MEDICINES INC 1,33%
MODERNA INC 1,32%
INSMED INC 1,31%
CG ONCOLOGY INC 1,3%
SPYRE THERAPEUTICS INC 1,29%
RHYTHM PHARMACEUTICALS INC 1,29%
REGENERON PHARMACEUTICALS 1,28%
ERASCA INC 1,27%
TRAVERE THERAPEUTICS INC 1,25%
VAXCYTE INC 1,23%
ROIVANT SCIENCES LTD 1,22%
RELAY THERAPEUTICS INC 1,2%
AMGEN INC 1,18%
BIOMARIN PHARMACEUTICAL INC 1,16%
ARROWHEAD PHARMACEUTICALS IN 1,15%
BRIDGEBIO PHARMA INC 1,15%
SCHOLAR ROCK HOLDING CORP 1,15%
COGENT BIOSCIENCES INC 1,13%
VIKING THERAPEUTICS INC 1,13%
VERTEX PHARMACEUTICALS INC 1,13%
INCYTE CORP 1,09%
GILEAD SCIENCES INC 1,08%
ACADIA PHARMACEUTICALS INC 1,08%
UNIQURE NV 1,08%
ALKERMES PLC 1,07%
ABBVIE INC 1,06%
CYTOKINETICS INC 1,04%
CRISPR THERAPEUTICS AG 1,04%
BIOGEN INC 1,03%
DYNE THERAPEUTICS INC 1,03%
IMMUNOVANT INC 1,03%
MADRIGAL PHARMACEUTICALS INC 1,03%
SELLAS LIFE SCIENCES GROUP I 1,02%
KRYSTAL BIOTECH INC 1%
MIRUM PHARMACEUTICALS INC 1%
SUMMIT THERAPEUTICS INC 1%
TG THERAPEUTICS INC 0,98%
CELCUITY INC 0,93%
PTC THERAPEUTICS INC 0,93%
GRAIL INC 0,93%
ULTRAGENYX PHARMACEUTICAL IN 0,93%
EXELIXIS INC 0,92%
IMMUNITYBIO INC 0,91%
IOVANCE BIOTHERAPEUTICS INC 0,91%
BIOCRYST PHARMACEUTICALS INC 0,9%
NEUROCRINE BIOSCIENCES INC 0,89%
UNITED THERAPEUTICS CORP 0,88%
BEAM THERAPEUTICS INC 0,86%
CELLDEX THERAPEUTICS INC 0,83%
VIRIDIAN THERAPEUTICS INC 0,83%
DENALI THERAPEUTICS INC 0,83%
IDEAYA BIOSCIENCES INC 0,81%
SAREPTA THERAPEUTICS INC 0,79%
IMMUNOME INC 0,76%
ALNYLAM PHARMACEUTICALS INC 0,74%
DISC MEDICINE INC 0,73%
VERA THERAPEUTICS INC 0,73%
IONIS PHARMACEUTICALS INC 0,73%
ARCUTIS BIOTHERAPEUTICS INC 0,72%
ARCUS BIOSCIENCES INC 0,71%
TANGO THERAPEUTICS INC 0,71%
MINERALYS THERAPEUTICS INC 0,7%
ADMA BIOLOGICS INC 0,7%
RECURSION PHARMACEUTICALS A 0,7%
INTELLIA THERAPEUTICS INC 0,65%
SYNDAX PHARMACEUTICALS INC 0,64%
AGIOS PHARMACEUTICALS INC 0,64%
NURIX THERAPEUTICS INC 0,64%
PALVELLA THERAPEUTICS INC 0,61%
VERACYTE INC 0,61%
NOVAVAX INC 0,59%
KODIAK SCIENCES INC 0,57%
BIOHAVEN LTD 0,54%
CAREDX INC 0,52%
VERICEL CORP 0,51%
STOKE THERAPEUTICS INC 0,47%
ABSCI CORP 0,47%
CULLINAN THERAPEUTICS INC 0,45%
PRECIGEN INC 0,44%
ORIC PHARMACEUTICALS INC 0,43%
XENCOR INC 0,43%
VIR BIOTECHNOLOGY INC 0,43%
CORVUS PHARMACEUTICALS INC 0,43%
ANAPTYSBIO INC 0,42%
HYPERLIQUID STRATEGIES 0,41%
REPLIMUNE GROUP INC 0,4%
FIRST TRACKS BIOTHERAPEUTICS 0,39%
VOR BIOPHARMA INC 0,39%
AVALO THERAPEUTICS INC 0,38%
ZENAS BIOPHARMA INC 0,38%
INHIBRX BIOSCIENCES INC 0,37%
Alle anzeigen Verstecken
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.